🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

John Hussman’s NEO Holdings & Trades

First Buy
Q2 2018
Duration Held
14 Quarters
Largest Add
Q2 2018
+150,000 Shares
Current Position
105,000 Shares
$1.93 M Value

John Hussman's NEO Position Overview

John Hussman (via Hussman Strategic Advisors, Inc.) currently holds 105,000 shares of NeoGenomics, Inc. (NEO) worth $1.93 M, representing 0.41% of the portfolio. First purchased in 2018-Q2, this medium-term investment has been held for 14 quarters.

Based on 13F filings, John Hussman has maintained a strategic position in NEO, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2026, adding 105,000 shares. Largest reduction occurred in Q2 2019, reducing 100,000 shares.

Analysis based on 13F filings available since 2013 Q2

John Hussman's NeoGenomics (NEO) Holding Value Over Time

Track share changes against reported price movement

Quarterly NeoGenomics (NEO) Trades by John Hussman

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q3 2026 +105,000 New Buy 105,000 $18.36
Q1 2024 -26,250 Sold Out 0 $0.00
Q3 2023 +26,250 New Buy 26,250 $12.30
Q3 2020 -20,000 Sold Out 0 $0.00
Q2 2020 -5,000 Reduce 20.00% 20,000 $31.00
Q4 2019 -75,000 Reduce 75.00% 25,000 $29.24
Q2 2019 -100,000 Reduce 50.00% 100,000 $21.94
Q3 2018 +50,000 Add 33.33% 200,000 $15.35
Q2 2018 +150,000 New Buy 150,000 $13.11

John Hussman's NeoGenomics Investment FAQs

John Hussman first purchased NeoGenomics, Inc. (NEO) in Q2 2018, acquiring 150,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

John Hussman has held NeoGenomics, Inc. (NEO) for 14 quarters since Q2 2018.

John Hussman's largest addition to NeoGenomics, Inc. (NEO) was in Q2 2018, adding 150,000 shares worth $1.97 M.

According to the latest 13F filing for Q3 2026, John Hussman's firm, Hussman Strategic Advisors, Inc., owns 105,000 shares of NeoGenomics, Inc. (NEO), valued at approximately $1.93 M.

As of the Q3 2026 filing, NeoGenomics, Inc. (NEO) represents approximately 0.41% of John Hussman's publicly disclosed stock portfolio, making it one of their key holdings.

John Hussman's peak holding in NeoGenomics, Inc. (NEO) was 200,000 shares, as reported at the end of Q3 2018.